A Randomized Trial of Changing Medication Adherence In Hypertensive African-American Patients

Completed · Not applicable

Conditions studied: Hypertension

In brief

The long-term objective is to determine whether better adherence to prescribed medications can be achieved through positive affect induction and self-affirmation leading to reduction in hypertension-related outcomes such as end-stage renal disease, stroke, and cardiovascular mortality among African American patients with poorly controlled hypertension.

Key facts

Study ID

NCT00248872

Run by

Weill Medical College of Cornell University

People needed

278

Starts

2004-10-01

Expected to finish

2008-07-01

Last updated by the study team

2017-02-23

Who can join

Age: 18 and older, up to 110. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be self-identified as African-Americans.
• All patients must be aged 18 years and older.
• All patients must be diagnosed as having hypertension: For this project, hypertension will be defined according to the widely accepted criteria of the 6th Joint National Committee (JNC VI) Guidelines on Prevention, Detection, Evaluation and Treatment of Hypertension, which is a systolic blood pressure > 140 mm hg or a diastolic blood pressure > 90 mm hg or if participants are taking any prescribed antihypertensive medication.
• Patients must be able to provide informed consent in English.

You may not qualify if…

• Patients who are unable to walk several blocks for any reason.
• Patients who refused to participate
• Patients who are unable to provide informed consent.

Where it is running

• The New York Presbyterian Hospital-Weill Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.